BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1389 related articles for article (PubMed ID: 11015608)

  • 21. Immune response to adenovirus-delivered antigens upregulates utrophin and results in mitigation of muscle pathology in mdx mice.
    Yamamoto K; Yuasa K; Miyagoe Y; Hosaka Y; Tsukita K; Yamamoto H; Nabeshima YI; Takeda S
    Hum Gene Ther; 2000 Mar; 11(5):669-80. PubMed ID: 10757347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice.
    Yang L; Lochmuller H; Luo J; Massie B; Nalbantoglu J; Karpati G; Petrof BJ
    Gene Ther; 1998 Mar; 5(3):369-79. PubMed ID: 9614557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M; Ehara Y; Li J; Inada K; Ohno K
    Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
    D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
    Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy.
    Krag TO; Gyrd-Hansen M; Khurana TS
    Acta Physiol Scand; 2001 Mar; 171(3):349-58. PubMed ID: 11412148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin.
    Gilbert R; Dudley RW; Liu AB; Petrof BJ; Nalbantoglu J; Karpati G
    Hum Mol Genet; 2003 Jun; 12(11):1287-99. PubMed ID: 12761044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis.
    Law DJ; Allen DL; Tidball JG
    J Cell Sci; 1994 Jun; 107 ( Pt 6)():1477-83. PubMed ID: 7962191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects.
    Banks GB; Chamberlain JS; Odom GL
    PLoS Genet; 2020 Nov; 16(11):e1009179. PubMed ID: 33175853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm.
    Petrof BJ; Acsadi G; Jani A; Massie B; Bourdon J; Matusiewicz N; Yang L; Lochmüller H; Karpati G
    Am J Respir Cell Mol Biol; 1995 Nov; 13(5):508-17. PubMed ID: 7576685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-generation compound for the modulation of utrophin in the therapy of DMD.
    Guiraud S; Squire SE; Edwards B; Chen H; Burns DT; Shah N; Babbs A; Davies SG; Wynne GM; Russell AJ; Elsey D; Wilson FX; Tinsley JM; Davies KE
    Hum Mol Genet; 2015 Aug; 24(15):4212-24. PubMed ID: 25935002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.
    Odom GL; Gregorevic P; Allen JM; Finn E; Chamberlain JS
    Mol Ther; 2008 Sep; 16(9):1539-45. PubMed ID: 18665159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes.
    Matecki S; Dudley RW; Divangahi M; Gilbert R; Nalbantoglu J; Karpati G; Petrof BJ
    Am J Physiol Lung Cell Mol Physiol; 2004 Sep; 287(3):L569-76. PubMed ID: 15155269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant micro-genes and dystrophin viral vectors.
    Dickson G; Roberts ML; Wells DJ; Fabb SA
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S40-4. PubMed ID: 12206793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease.
    Gibbs EM; McCourt JL; Shin KM; Hammond KG; Marshall JL; Crosbie RH
    Hum Mol Genet; 2021 Apr; 30(3-4):149-159. PubMed ID: 33432327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human α7 Integrin Gene (ITGA7) Delivered by Adeno-Associated Virus Extends Survival of Severely Affected Dystrophin/Utrophin-Deficient Mice.
    Heller KN; Montgomery CL; Shontz KM; Clark KR; Mendell JR; Rodino-Klapac LR
    Hum Gene Ther; 2015 Oct; 26(10):647-56. PubMed ID: 26076707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route.
    Cho WK; Ebihara S; Nalbantoglu J; Gilbert R; Massie B; Holland P; Karpati G; Petrof BJ
    Hum Gene Ther; 2000 Mar; 11(5):701-14. PubMed ID: 10757350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
    Tinsley JM; Potter AC; Phelps SR; Fisher R; Trickett JI; Davies KE
    Nature; 1996 Nov; 384(6607):349-53. PubMed ID: 8934518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.
    Parvatiyar MS; Brownstein AJ; Kanashiro-Takeuchi RM; Collado JR; Dieseldorff Jones KM; Gopal J; Hammond KG; Marshall JL; Ferrel A; Beedle AM; Chamberlain JS; Renato Pinto J; Crosbie RH
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.